Sign in Join
Daily desk

News

Artificial intelligence, technology, science, health and education — reported daily, with the original source attached to every item.

Showing articles about nejm

2 stories

A dual-receptor (GLP-1 + glucagon) icon alongside the headline 13.1% average weight loss figure from the SYNCHRONIZE-2 trial, with stat tiles for HbA1c drop and treatment discontinuation.
🩺 Health Study

Phase 3 Trial Finds Dual-Agonist Drug Survodutide Cuts Weight 13.1% in Adults With Type 2 Diabetes

A phase 3 trial published in NEJM on October 1, 2026 found that weekly survodutide, a dual glucagon/GLP-1 receptor agonist, produced up to …

EduFabTech · 4h ago · 4 min read
A single IV infusion generates CAR T cells inside the body that clear CD19-positive B cells, in a 16-patient trial spanning four autoimmune diseases with mostly mild side effects.
🩺 Health Study

Single-Infusion In Vivo CAR T-Cell Therapy Eases Four Neurologic Autoimmune Diseases in Small NEJM Trial

A 16-patient trial published in NEJM on September 3, 2026 tested a single-infusion lentiviral vector that generates CD19 CAR T cells inside…

EduFabTech · 6d ago · 4 min read